|
MLF2 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.6636692024008E-12 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.83186799063151E-14 |
| Normal-vs-Stage2 |
1.27529997673292E-09 |
| Normal-vs-Stage3 |
4.69824179560874E-12 |
| Normal-vs-Stage4 |
1.591920E-02 |
| Stage1-vs-Stage2 |
1.681410E-01 |
| Stage1-vs-Stage3 |
7.122800E-01 |
| Stage1-vs-Stage4 |
1.775720E-02 |
| Stage2-vs-Stage3 |
3.490200E-01 |
| Stage2-vs-Stage4 |
5.301700E-03 |
| Stage3-vs-Stage4 |
1.598170E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
9.99200722162641E-16 |
| Normal-vs-AfricanAmerican |
1.037840E-01 |
| Normal-vs-Asian |
3.835200E-01 |
| Caucasian-vs-AfricanAmerican |
8.358300E-03 |
| Caucasian-vs-Asian |
5.491200E-01 |
| AfricanAmerican-vs-Asian |
7.409200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.11022302462516E-16 |
| Normal-vs-Female |
2.47110000017869E-07 |
| Male-vs-Female |
7.75470000000666E-05 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.780000E-02 |
| Normal-vs-Age(41-60Yrs) |
6.14508444130024E-12 |
| Normal-vs-Age(61-80Yrs) |
1.74549263931567E-12 |
| Normal-vs-Age(81-100Yrs) |
1.1680999999486E-06 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.983600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.561400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.726400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.063200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.859600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.864800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
2.185400E-04 |
| Normal-vs-Grade 2 |
1.0991207943789E-14 |
| Normal-vs-Grade 3 |
3.99913435700228E-12 |
| Normal-vs-Grade 4 |
5.900800E-03 |
| Grade 1-vs-Grade 2 |
7.005400E-01 |
| Grade 1-vs-Grade 3 |
7.785200E-01 |
| Grade 1-vs-Grade 4 |
1.884420E-01 |
| Grade 2-vs-Grade 3 |
7.301600E-01 |
| Grade 2-vs-Grade 4 |
1.535520E-02 |
| Grade 3-vs-Grade 4 |
2.218000E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.62436730732907E-12 |
| Normal-vs-ccB subtype |
1.87139193030816E-12 |
| ccA subtype-vs-ccB subtype |
2.348400E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.448663659673E-13 |
| Normal-vs-N1 |
7.785600E-01 |
| N0-vs-N1 |
6.839600E-02 |
|
|
